The Effects of a Daily Skincare Regimen on Maintaining the Benefits Obtained from Previous Chemical Resurfacing Treatments

September 2016 | Volume 15 | Issue 9 | Features | 1145 | Copyright © September 2016


Suzanne Bruce MD,a Wendy Roberts MD,b Craig Teller MD,c and Lora Colvan BSd

aSuzanne Bruce and Associates, Houston, TX
bRancho Mirage Dermatology, Rancho Mirage, CA
cBellaire Dermatology Associates, Bellaire, TX
dMDRejuvena, Inc., San Diego, CA

table 2

Assessments

Assessments were performed at baseline and week 12 by physician and included rating the severity of the following parameters. A 5-point scale was employed for these assessments (1 = mild, 3 = moderate, 5 = severe).
  • Fine Lines
  • Coarse Wrinkles
  • Skin Roughness
  • Brown Spots
  • Skin Discoloration
  • Global Assessment Rating (week 12 only)

    The subject week 12 self-assessment included the following parameters. A 5-point scale was used for these assessments (1 = worse, 2 = no improvement, 3 = mild improvement, 4 = moderate improvement, and 5 = marked improvement).
  • Fine Lines
  • Coarse Wrinkles
  • Skin Roughness
  • Brown Spots
  • Skin Discoloration
  • Overall Assessment Rating (week 12 only)

    For the Global and Overall Assessment ratings at week 12, both the physician and subjects used the following scale:
    table 3

    RESULTS

    Thirteen subjects who completed the skin resurfacing trial participated in the 12-week continuation trial. See Table 1 for demographics. The subjects ranged in age from 46 to 65 years, and included Fitzpatrick skin types I-IV. Eight of the subjects had undergone the AGE resurfacing treatment, and five had undergone the MELA resurfacing treatment in the skin resurfacing protocol. All subjects used the MDRejuvena continuation skin care regimen for 12 weeks as directed.
    Results of the physician and subject assessments at week 12 are shown in Figure 1. According to the physician’s global assessment at week 12, 7 subjects (54%) showed mild improvement, 1 subject (8%) showed moderate improvement and 5 subjects (38%) showed marked improvement.
    According to the subject overall assessment at week 12, 1 subject (8%) saw no improvement, 4 subjects (31%) saw mild improvement, 4 subjects (31%) saw moderate improvement, and 3 subjects (23%) saw marked improvement; 1 subject (7%) did not provide an overall assessment.
    table 4